Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 75.95
+0.85 (1.13%)
Aug 19, 2025, 11:44 AM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 14.52 billion as of August 18, 2025.
Market Cap
14.52B
Enterprise Value
14.27B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
75.95
Market Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has increased from 12.97B to 14.52B, an increase of 11.92%. That is a compound annual growth rate of 454.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2025 | 14.52B | 8.29% |
| Aug 15, 2025 | 13.41B | 5.24% |
| Aug 14, 2025 | 12.74B | -3.94% |
| Aug 13, 2025 | 13.26B | 0.37% |
| Aug 12, 2025 | 13.22B | 2.78% |
| Aug 11, 2025 | 12.86B | -3.27% |
| Aug 8, 2025 | 13.29B | -2.83% |
| Aug 7, 2025 | 13.68B | -1.67% |
| Aug 6, 2025 | 13.91B | -4.00% |
| Aug 5, 2025 | 14.49B | 4.83% |
| Aug 4, 2025 | 13.83B | 2.14% |
| Aug 1, 2025 | 13.54B | -2.98% |
| Jul 31, 2025 | 13.95B | -5.87% |
| Jul 30, 2025 | 14.82B | -1.48% |
| Jul 29, 2025 | 15.04B | 6.14% |
| Jul 28, 2025 | 14.17B | 9.24% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 276.65B |
| Hansoh Pharmaceutical Group Company | 221.78B |
| JD Health International | 196.01B |
| Innovent Biologics | 166.99B |
| Akeso | 148.55B |
| Sino Biopharmaceutical | 139.86B |
| WuXi Biologics | 125.94B |
| CSPC Pharmaceutical Group | 125.31B |